Get the Stockscreener App
1.84
2.14%
-0.03
Cyclerion Therapeutics Inc stock is traded at $1.84, with a volume of 41,620.
It is down -2.14% in the last 24 hours and down -26.80% over the past month.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$1.87
Open:
$1.88
24h Volume:
41,620
Relative Volume:
0.12
Market Cap:
$6.14M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-0.8598
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
-12.86%
1M Performance:
-26.80%
6M Performance:
-41.80%
1Y Performance:
-37.97%
1-Day Range:
$1.72
$1.88
1-Week Range:
$1.72
$2.12
52-Week Range:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Name
Cyclerion Therapeutics Inc
Sector
Industry
Phone
617-621-7722
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.84 | 5.99M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-21 | Initiated | Truist | Buy |
| Sep-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-03-19 | Initiated | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Stock (CYCN) Latest News
What institutional flow reveals about Cyclerion Therapeutics Inc.Entry Point & Smart Investment Allocation Insights - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth storyJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analysts2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsGlobal Markets & Accurate Trade Setup Notifications - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Trade Entry Summary & Weekly Setup with ROI Potential - newser.com
Short interest data insights for Cyclerion Therapeutics Inc.Portfolio Risk Summary & Comprehensive Market Scan Reports - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionJuly 2025 Summary & Daily Price Action Insights - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Trade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Should you hold or exit Cyclerion Therapeutics Inc. nowQuarterly Portfolio Report & Weekly Chart Analysis and Guides - newser.com
Is Cyclerion Therapeutics Inc. stock recession proof2025 Trade Ideas & High Win Rate Trade Tips - newser.com
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsPortfolio Risk Summary & Daily Stock Trend Watchlist - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityTrade Ideas & Daily Profit Maximizing Tips - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fake2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
How Cyclerion Therapeutics Inc. stock reacts to inflationary pressuresQuarterly Market Review & Fast Gaining Stock Reports - newser.com
What high frequency data says about Cyclerion Therapeutics Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
What MACD and RSI say about Cyclerion Therapeutics Inc.Quarterly Trade Summary & Capital Efficiency Focused Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock entering bullish territoryWeekly Market Report & Risk Controlled Swing Alerts - newser.com
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatPortfolio Value Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-30 23:30:48 - newser.com
Cyclerion Therapeutics Inc Stock (CYCN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):